Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
News|Articles|July 27, 2026
CMS' obstetric G-codes draw concern, HIV screening recommendation strengthened, Roche's BV/CV assay clearance
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Ben Saylor
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Advertisement
Advertisement
Thank you for visiting the Contemporary OB/GYN website. Take a look at some of our top stories from the past week (Monday, July 20, to Friday, July 24, 2026) and click on each link to read and watch anything you may have missed.
Related to this article
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
Missed the rollout of ACOG's 2026 Maternal Immunization Schedule? This FAQ breaks down everything clinicians need to know about the new guidance.
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.
The Preeclampsia Foundation released 2 videos on postpartum recovery and long-term health after HDP.
Advertisement
Advertisement